Amgen to Present Data from Multiple Early-Stage Clinical Trials at Esmo 2024
January 2, 2025
Amgen announced the presentation of new data across its broad oncology pipeline and portfolio at the European Society for Medical Oncology (ESMO) Congress 2024, taking